Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Types of RNA01:20

Types of RNA

13.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
13.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.7K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

934
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
934
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

811
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
811

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A novel chimeric peptide binds MC3T3‑E1 cells to titanium and enhances their proliferation and differentiation.

Molecular medicine reports·2013
Same author

Fast trabecular bone strength predictions of HR-pQCT and individual trabeculae segmentation-based plate and rod finite element model discriminate postmenopausal vertebral fractures.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2013
Same author

Biological activities and corresponding SARs of andrographolide and its derivatives.

Mini reviews in medicinal chemistry·2013
Same author

The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis.

Familial cancer·2013
Same author

Understanding the structure and mechanism of formation of a new magnetic microbubble formulation.

Theranostics·2013
Same author

Analysis of IL-17 gene polymorphisms in Chinese patients with dilated cardiomyopathy.

Human immunology·2013

Video Experimental Relacionado

Updated: Apr 25, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

7.5K

Un largo ARN no codificante protege el corazón de la hipertrofia patológica.

Pei Han1,2, Wei Li1, Chiou-Hong Lin1

  • 1Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305.

Nature
|August 15, 2014
PubMed
Resumen

Un ARN largo no codificante recién descubierto específico para el corazón, Mhrt, protege el corazón adulto inhibiendo el remodelador de cromatina Brg1. La pérdida de Mhrt es esencial para el desarrollo de la insuficiencia cardíaca, pero su restauración previene la disfunción cardíaca.

Más Videos Relacionados

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

19.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

Videos de Experimentos Relacionados

Last Updated: Apr 25, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

7.5K
Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

19.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

Área de la Ciencia:

  • Biología Molecular Biología Molecular
  • Genética La genética.
  • Cardiología Cardiología.

Sus antecedentes:

  • El papel de los ARN largos no codificantes (ARNlnc) en la función cardíaca adulta y su modulación de la remodelación del nucleosoma siguen siendo en gran medida desconocidos.
  • La transcripción antisense es prevalente, con la miosina de cadena pesada 7 (Myh7) siendo un gen clave que codifica proteínas esenciales para la contracción del corazón.

Objetivo del estudio:

  • Para identificar y caracterizar nuevos lncRNAs en el corazón adulto.
  • Para dilucidar el mecanismo por el cual los lncRNAs interactúan con complejos de remodelación de la cromatina.
  • Investigar el papel de estos lncRNAs en el desarrollo de la insuficiencia cardíaca y la cardiomiopatía.

Principales métodos:

  • Identificación y caracterización de transcripciones de lncRNA específicas para el corazón de los loci Myh7 en ratones, llamados Mhrt.
  • Investigación de la interacción de Mhrt con el complejo represor de cromatina Brg1-Hdac-Parp bajo estrés patológico.
  • Análisis del papel de Mhrt en la prevención de la unión de Brg1 a los objetivos del ADN genómico y su impacto en la remodelación de la cromatina.

Principales resultados:

  • Mhrt es un lncRNA abundante y específico del corazón en corazones adultos que es reprimido por el estrés patológico a través del complejo Brg1-Hdac-Parp.
  • La represión de Mhrt es esencial para el desarrollo de la cardiomiopatía; restaurar los niveles de Mhrt protege contra la hipertrofia y la insuficiencia cardíaca.
  • Mhrt se une directamente al dominio helicasa de Brg1, inhibiendo competitivamente su actividad de unión al ADN y previniendo la expresión génica aberrante y la miopatía cardíaca.

Conclusiones:

  • Un nuevo mecanismo lncRNA-cromatina que involucra a Mhrt y Brg1 es crucial para mantener la función cardíaca.
  • Mhrt actúa como un factor cardioprotector al antagonizar la remodelación de la cromatina inducida por el estrés.
  • Este estudio establece un nuevo paradigma para las interacciones lncRNA-cromatina e identifica un mecanismo conservado en la cardiomiopatía humana.